In the News

Al Sharpton delivered the keynote address for the Black Health Care Coalition, speaking out against the health care of black people and specifically Alzheimer’s. Turning his attention to the upcoming 2020 election, Sharpton says “All of the candidates running for President of the United States have health plans and should be focusing to eliminate the […]

CLEVELAND, Ohio — Alzheimer’s disease afflicts nearly 6 million people in the United States, and sadly affects the many more millions of people who love them. Yet the chairman and co-founder of UsAgainstAlzheimer’s believes that most people — especially those who could help make a difference — don’t grasp the overall scope and impact of […]

CLEVELAND, Ohio — The long quest to find a cure for Alzheimer’s disease could become discouraging. But ordinary people won’t allow that. They are a source of encouragement for doctors and researchers dedicated to stifling the disease, and for the people stricken by it. “Participating in a clinical trial gives me and others the opportunity […]

Two RSF Research and Innovation Center patients have been honored as nominees for the Citizen Scientist Award celebrating Alzheimer’s disease clinical trial participants. Wayne Vereen and Sharon Fratepietro have been clinical trial volunteer patients at the RSF Research and Innovation Center for more than four years, and during that time, they’ve received monthly infusions on site. […]

With support from the nonprofit Global Alzheimer’s Platform Foundation, Advocate Lutheran General Hospital and Advocate Research Institute recently honored patients with Alzheimer’s disease and their care partners who have participated in Alzheimer’s disease research at the Advocate Memory Center. This local ceremony is part of the inaugural Citizen Scientist Awards® Program, the first national awards […]

GAP-Net site Okanagan Clinical Trials in Kelowna, BC recognized three of its Citizen Scientist Awards nominees in a ceremony at the Okanagan Innovation Centre in downtown Kelowna. A dozen times over two years, Gary Millward and his wife, Debra, drove from Quesnel to Kelowna through everything from wildfires and winter storms to rain and brilliant […]

A podcast discussing Alzheimer’s disease – research, risk prevention, and other related topics. Robert Herriman is joined by Phil Sabel, M.A., the Clinical Research Coordinator at GAP-Net site Axiom Clinical Research in Tampa. Click here to listen to the June 13, 2019 episode.

By the time I was old enough to ask my grandmother questions about her life, it was too late. All I had were skeletons of stories I heard from my mom. I knew that it had been difficult for my grandmother when her parents, Irish immigrants on the vaudeville circuit, left her behind to help […]

The threat of Alzheimer’s disease looms over an aging America, but could a cure be in the offing? And if so, how soon? Experts say the answer is “yes” — and by the year 2025. That’s the date they’re shooting for, anyway. Much as President Kennedy once vowed to send a man to the moon […]

AzBusiness recognized Dr. Anna Burke as its 2019 Healthcare Innovator of the Year for her work in treating the behavioral and psychiatric disturbances that result from Alzheimer’s disease as well as her work building a community outreach program in the Phoenix area to teach people about brain health, Alzheimer’s, and clinical research. Dr. Burke is […]

The majority of experts agree that because Alzheimer’s disease is significantly underdiagnosed and underreported, a large number of people may not know they have it.  We have both spoken at length about the importance of early detection and diagnosis to allow for earlier interventions and care planning along with a broad array of methods and […]

The Alzheimer’s disease space is not an easy one for pharma companies to navigate. In 2018 alone, Lundbeck, Takeda, Merck, Janssen, AstraZeneca, and Eli Lilly and Company all faced setbacks or poor trial results. In March 2019, we learned that Biogen and Eisai also terminated late-phase studies. Fortune magazine notes few spaces in the life […]

Outside the daffodils and forsythia were blooming, but the group assembled in Nashville, Tennessee, hardly took notice. At the GAP-Net Site Optimization Conference, held February 27–March 1, representatives of 61 academic and private clinical trial sites had eyes and minds trained on efforts aiming to improve how Alzheimer’s disease clinical trials are done—and after years […]

The Global Alzheimer’s Platform (GAP) Foundation, an organization dedicated to improving Alzheimer’s clinical trials in the quest of a cure, has just wrapped the GAP-NET Site Optimization Conference in Nashville. The Feb. 27-March 1 meeting brought together approximately 150 representatives from its network of Alzheimer’s clinical research sites. The third annual GAP-NET conference attracted the […]

Clinical trials represent future hope for patients seeking better care, and there is no disease more in need of better care than Alzheimer’s disease. While death rates among most cancers, as well as heart disease, HIV-related illness, and other categories, have declined in the past decade, there has been no progress for Alzheimer’s disease. Better […]

There are many open, important clinical trials in Tennessee right now targeting Alzheimer’s disease and related conditions. It’s been 18 months since Nashville legend Glen Campbell died after a long battle with Alzheimer’s disease. Glen and his family bravely shared his heartbreaking journey in the hope of inspiring better care and research for the disease, […]

Top Alzheimer’s Researchers Hope That Near-100 Dementia Drugs in Trials Are Moving Closer to a Breakthrough The search for a drug to treat Alzheimer’s disease, the most common form of dementia, has been marked by clinical trial failures. A new report from top researchers says the number of drugs advancing through clinical phase two and […]

Alzheimer’s clinical trial participants are getting a lift to their appointments at Raleigh Neurology Associates. The Global Alzheimer’s Platform Foundation, in partnership with Lyft, is providing transportation to participants in an Eli Lilly study testing a therapy to attack plaque in the brain characteristic of Alzheimer’s disease. Sean Walsh, director of clinical research at Raleigh Neurology Associates, says the new […]

Curing diseases requires new drugs. Getting those new drugs approved by regulators requires data from successful clinical trials. Those trials depend on patients, and right now getting those patients is a challenge for many sponsor companies. According to research performed on recruitment, 85 percent of trials are delayed due to enrollment issues and more than […]

Growing up as an African-American in the South over 75 years ago, my family didn’t have the access to medical care we do today. One event from my childhood changed my life.  My mother went to the doctor’s office. She was quite ill and needed help. The doctor said she had to wait to be […]

The U.S. Congress last week authorized an additional 40 percent in funds for Alzheimer’s disease (AD) research, boosting the fiscal 2017 total by $400 million to nearly $1.4 billion as part of a $2 billion year-over-year increase for the National Institutes of Health (NIH). The final package won praise from the nonprofit Global Alzheimer’s Platform Foundation (GAP), […]

Ann Poehler’s strides quicken on the treadmill. Her feet pound. Her heart races from 150 to 160 beats per minute and more. A plastic tube jutting from the Prairie Village woman’s mouth feeds carbon dioxide levels to a computer here inside the University of Kansas Alzheimer’s Disease Center. The computer records every respiration while an exercise […]

A recent online survey conducted by Harris Poll found that nearly 60% of Americans are definitely willing or willing to consider taking part in a clinical trial for Alzheimer’s. This promising statistic is good news for researchers; however, obtaining qualified trial participants has been one of the greatest challenges in getting clinical trials off the […]